• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Oncolytics Biotech released FY2025 9 Months earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -0.2067
04:00
Oncolytics Biotech released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.102 (forecast USD -0.0616)
04:00
Oct28
Oncolytics Biotech Reports 30% Response Rate for Anal Cancer Combination Therapy
11:31
Aug8
Oncolytics Biotech released FY2025 Q2 earnings on August 8 Pre-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0494 (forecast USD -0.0737)
13:30
Oncolytics Biotech released FY2025 Semi-Annual Earnings on August 8 Pre-Market EST, with actual revenue of USD 0 and EPS of USD -0.1045
13:30
Aug1
Oncolytics Biotech to Release FY2025 Q2 Earnings on August 8 Pre-Market EST, Forecast Revenue USD 0, EPS USD -0.0729
00:05

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -10.34 M, EPS -0.102

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.5 M, EPS -0.0494

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.671 M, EPS -0.0551

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
ASTX
46.070
+36.50%
+12.320
ABLV
0.9715
+34.87%
+0.251
View More